Drug Profile
Bectumomab
Alternative Names: Anti-CD22 monoclonal antibody LL2 Tc 99m; ImmuRAID LL2 Tc 99m; LymphoScanLatest Information Update: 27 Oct 2020
Price :
$50
*
At a glance
- Originator Immunomedics
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma
Most Recent Events
- 23 Oct 2020 Immunomedics has been acquired by Gilead Sciences
- 18 Sep 2003 Suspended - Phase-III for Non-Hodgkin's lymphoma (diagnosis) in European Union (IV)
- 18 Sep 2003 Suspended - Phase-III for Non-Hodgkin's lymphoma (diagnosis) in USA (IV)